Watchtower Advisors’s Verona Pharma VRNA Stock Holding History

Watchtower Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-70,000	Closed	-$7.47M	–	17
2025 Q3	$7.47M	Hold	70,000	–	–	3.48%	16
2025 Q2	$6.62M	Sell	70,000 -75,338	-52%	-$5.58M	3.92%	12
2025 Q1	$9.23M	Sell	145,338 -91,435	-39%	-$5.47M	6.7%	5
2024 Q4	$11M	Buy	+236,773	New	+$8.89M	6.22%	10

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Watchtower Advisors's VRNA Position: Q4 2025 in Review

Watchtower Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 70,000 shares — an estimated $7.47M sold.

Watchtower Advisors first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $11M in Q4 2024. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Watchtower Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Watchtower Advisors sold 70,000 Verona Pharma shares in Q4 2025, an estimated $7.47M.
Watchtower Advisors first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
Watchtower Advisors's Verona Pharma position peaked at $11M in Q4 2024.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Watchtower Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.